CDMO News
Autolomous Partners with BioCentriq to Accelerate Cell Therapy Development
Autolomous, the developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, a clinical-phase Cell Therapy CDMO have announced a collaboration to digitise and accelerate process development and manufacturing activities. BioCentriq will leverage Autolomous’ autoloMATE platform to streamline
4 April 2024